For the quarter ending 2026-01-31.
| Income Statement | 2026-01-31 | 2025-10-31 | 2025-07-31 | |
|---|---|---|---|---|
| Research and development | 22,255 | 26,755* | 22,575 | |
| General and administrative | 8,930 | 6,569* | 7,372 | |
| Total operating expenses | 31,185 | 33,324 | 29,947 | |
| Loss from operations | -31,185 | -33,324* | -29,947 | |
| Interest income | 2,740 | 2,727* | 2,233 | |
| Interest expense | 732 | 720* | 758 | |
| Loss on extinguishment of debt | -488 | 0* | - | |
| Other expenses (income), net | -87 | 271* | -280 | |
| Total other income, net | 1,433 | 2,278* | 1,195 | |
| Net loss before income taxes | -29,752 | -31,046* | -28,752 | |
| Provision for income taxes | 0 | -717* | 239 | |
| Net loss | -29,752 | -30,329* | -28,991 | |
| Unrealized gain on available-for-sale investments | 46 | 1,251* | -240 | |
| Total comprehensive loss | -29,706 | -29,078 | -29,231 | |
| Basic EPS | 0.44 | -0.569 | 0.57 | |
| Diluted EPS | 0.44 | -0.569 | 0.57 | |
| Basic Average Shares | 67,263,234 | 51,141,247 | 51,097,711 | |
| Diluted Average Shares | 67,263,234 | 51,141,247 | 51,097,711 | |
enGene Holdings Inc. (ENGN)
enGene Holdings Inc. (ENGN)